Similar articles

• Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease).

  Krivit W, Desnick RJ, Lee J, Moller J, Wright F, Sweeley CC, Snyder PD Jr, Sharp HL. Krivit W, et al. Am J Med. 1972 Jun;52(6):763-70. doi: 10.1016/0002-9343(72)90082-4. Am J Med. 1972. PMID: 5030173 No abstract available.
• [Sphingolipidoses. Biochemistry and enzymatic mechanisms].

  Gajdos A. Gajdos A. Nouv Presse Med. 1972 Jun 24;1(26):1789-92. Nouv Presse Med. 1972. PMID: 5054020 French. No abstract available.
• [Biochemical aspects of sphingolipidosis].

  Douste-Blazy L, Thouvenot JP. Douste-Blazy L, et al. Ann Biol Clin (Paris). 1972;30(6):623-35. Ann Biol Clin (Paris). 1972. PMID: 4569435 Review. French. No abstract available.
• Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis.

  Svennerholm L, Fredman P, Jungbjer B, Månsson JE, Rynmark BM, Boström K, Hagberg B, Norén L, Santavuori P. Svennerholm L, et al. J Neurochem. 1987 Dec;49(6):1772-83. doi: 10.1111/j.1471-4159.1987.tb02435.x. J Neurochem. 1987. PMID: 3681296
• [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].

  Hirabayashi Y, Li YT, Li SC. Hirabayashi Y, et al. Seikagaku. 1983;55(1):1-13. Seikagaku. 1983. PMID: 6405000 Review. Japanese. No abstract available.